Dr. Juarez-Reyes received her PhD in Health Psychology, MD and Internal Medicine residency training from the University of California at San Francisco. Her focus during medical training was in Behavioral Medicine. In 2010, she became board certified in Integrative Medicine through American Board of Integrative Holistic Medicine. She is currently Assistant Clinical Professor in the Division of Primary Care and Population Health, Department of Medicine, Stanford University. She serves as Site Director for Internal Medicine Residency program at Stanford. She developed “Beyond Stress”, a six-week group intervention for patients with stress, anxiety, and depression and is the Director of Behavioral health Group Medical Visits. This intervention has now been translated into Spanish, Mas Alla del Estres, and it is delivered to community based Spanish speaking cancer patients.
Her current research evaluates integrative behavioral health group medical visits and the relationship to anxiety, depression, burnout, and sleep in primary care and Spanish speaking community-based populations. Her other health disparities research has been in tobacco cessation practices of community-based providers, breast cancer screening follow-up in Latinx women, Latinx adolescent reproductive behavior, medication eligibility criteria effects in ethnic subgroups, and TB treatment in urban county jails. She enjoys travel, walking with friends, anything science fiction and spending time with her family.
- Internal Medicine
- Women's Health
- Behavioral Medicine
Site Director, Internal Medicine Residency Program (2016 - Present)
Board Certification: American Board of Internal Medicine, Internal Medicine (2005)
Residency: UCSF-Graduate Medical Education (2001) CA
Medical Education: Univ of California San Francisco (1997) CA
M.D., U.C. San Francisco, Medicine (1997)
Ph.D., U.C. San Francisco, Psychology (1991)
B.A, San Jose State University, Psychology Neuroscience (1985)
Mindfulness-Based Group Medical Visits in Primary Care for Stress and Anxiety: An Observational Study.
Journal of integrative and complementary medicine
Background: The prevalence of anxiety disorders in primary care is 20%, with 41% of these patients reporting no current treatment. Patients with anxiety are also more likely to have comorbidities with other medical and/or psychiatric conditions, increasing medical costs. Integrating mindfulness-based interventions (MBIs) into a group medical visit (GMV) format has been successfully used to manage pain, but limited literature is available on the effectiveness of these visit formats for patients with stress and anxiety. Methods: Ninety-two adult patients with self-reported stress and/or anxiety were recruited from three university outpatient primary care clinics between 2016 and 2019. Participants attended at least 4 of 6 weekly GMVs focused on MBIs. Change in heart rate, blood pressure, Generalized Anxiety Disorder-7 (GAD-7) score, and 9 item Patient Health Questionnaire (PHQ-9) score from the first to last visit were evaluated using mixed effect linear regression models. Results: Both GAD-7 (estimated change: -5.1; 95% confidence interval [CI]: -6.4 to -3.7) and PHQ-9 (estimated change: -3.3; 95% CI: -4.3 to -2.2) scores significantly decreased from the first to last visit. These reductions were independent of age, sex, and number of visits attended. No significant changes in heart rate or blood pressure were found. Conclusions: Significant reductions in anxiety and depression in primary care patients were observed after a 6-week standardized mindfulness based GMV. Intergroup variability was not significant indicating that the intervention is reproducible over time and across providers. Future randomized controlled trials with appropriate controls will better evaluate which components of the intervention account for findings.
View details for DOI 10.1089/jicm.2021.0329
View details for PubMedID 35671517
Accessing behavioral health care during COVID: rapid transition from in-person to teleconferencing medical group visits.
Therapeutic advances in chronic disease
2021; 12: 2040622321990269
Background and aim: Effective and safe behavioral health interventions in primary care are critical during pandemic and other disaster situations. California shelter-in-place orders necessitated rapid transition of an effective mindfulness-based medical group visit (MGV) program from in-person to videoconferenced sessions (VCSs). Aim: to Describe procedures, acceptability, and feasibility of converting from in-person to VCS.Patients and methods: Methods: qualitative. Dataset: primary care. Intervention: a six-session 2-h MGV program with educational and mindfulness components was converted. Four in-person sessions and two VCSs were held. General Anxiety Disorder and Patient Health Questionnaire-9 were administered at first and last sessions. A semi-structured focus group was conducted after session six. Population studied: six primary care patients (42±11years) with stress, anxiety, or depression participated.Results: Procedural changes included remote material distribution, scheduling, hosting, and facilitation functions using the Zoom platform. The focus group revealed that patients preferred in-person sessions during initial visits, but appreciated transitioning to VCS, which provided continued support during a challenging time. Instruction on technical (e.g. logging on) and social (e.g. signaling next speaker) aspects of VCS was suggested. Building relationships through conversations was an important part before and after in-person sessions missing from VCS. Patients suggested combining in-person and VCS to allow relationship building while also improving access.Conclusion: While many procedural changes were needed to facilitate conversion to VCS, primary care patients seeking stress, anxiety, and depression interventions found VCS acceptable during COVID-19. Future iterations of this program are proposed which incorporate procedural changes and facilitate relationship building between patients in VCS.
View details for DOI 10.1177/2040622321990269
View details for PubMedID 33633823
Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail.
Open forum infectious diseases
2016; 3 (1): ofv220-?
In an urban jail population, 3 months of isoniazid and rifapentine (3HP) was associated with an 85% latent tuberculosis infection treatment completion rate compared with 18% in a standard 9-month isoniazid treatment group. Among the 91 patients who started 3HP therapy, there were 2 treatment discontinuations from adverse drug reactions.
View details for DOI 10.1093/ofid/ofv220
View details for PubMedID 26885547
View details for PubMedCentralID PMC4753347